Grewe M, Gyufko K, Schöpf E, Krutmann J
Department of Dermatology, University of Freiburg, Germany.
Lancet. 1994 Jan 1;343(8888):25-6. doi: 10.1016/s0140-6736(94)90879-6.
Atopic eczema is thought to be caused by skin-infiltrating CD4 T cells of the Th1-like and/or Th2-like subtype. We assessed expression of the Th1-like cytokine, interferon-gamma, and the Th2-like cytokine, interleukin-4, in lesional atopic skin. Compared with that in normal skin, interferon-gamma and interleukin-4 mRNA expression were increased in eczematous skin lesions in 13 and 4 of 15 patients, respectively. After successful therapy of atopic dermatitis, the increased interferon-gamma mRNA expression but not the increased interleukin-4 mRNA expression was significantly down-regulated. These data indicate that in-situ expression of interferon-gamma is linked to the clinical course of atopic dermatitis.
特应性皮炎被认为是由Th1样和/或Th2样亚型的皮肤浸润性CD4 T细胞引起的。我们评估了特应性皮损中Th1样细胞因子干扰素-γ和Th2样细胞因子白细胞介素-4的表达。与正常皮肤相比,15例患者中有13例和4例的湿疹性皮肤病变中干扰素-γ和白细胞介素-4 mRNA表达增加。特应性皮炎成功治疗后,增加的干扰素-γ mRNA表达显著下调,但增加的白细胞介素-4 mRNA表达未下调。这些数据表明,干扰素-γ的原位表达与特应性皮炎的临床病程有关。